CDP SWISS AG

CDP SWISS AG is a Swiss company specializing in high-quality medical and aesthetic products, leveraging innovative technology to deliver advanced solutions for healthcare and beauty professionals. Founded in 2006, CDP SWISS AG focuses on medical and aesthetic device manufacturing. The company operates out of Switzerland and has made one significant deal as of April 29, 2025. The founder’s detailed history is not disclosed, nor is it mentioned if they founded other companies or if the firm has subsidiaries.

CDP SWISS AG specializes in high-quality medical and aesthetic products, focusing on innovative technologies designed to meet the diverse needs of its clientele. Their core offerings include advanced laser systems such as the primelase®, recognized as one of the most powerful diode lasers globally, which efficiently facilitates hair removal across all skin types. Additionally, the company provides cutting-edge equipment like the ULTRApulse Alpha, a versatile device catering to various aesthetic treatments, and the Secret DUO, a fractional microneedling system that enhances skin treatment capabilities beyond traditional laser applications. These products serve a broad range of professionals in the medical beauty industry, including dermatologists and cosmetic practitioners, primarily in the Swiss and European markets, where they adhere to stringent regional quality standards.

CDP SWISS AG generates revenue through direct sales of its medical and aesthetic devices to healthcare and beauty professionals, fostering B2B relationships within the industry. Transactions typically involve one-time purchases of flagship products, accompanied by service contracts that ensure the ongoing support and maintenance of these sophisticated systems. The company also engages in educational initiatives, offering workshops and training sessions to clients to optimize the use of their equipment, which may contribute additionally to their revenue streams. Pricing structures for these products are based on the high-quality standards and advanced technology integrated into each device, reflecting the company's commitment to delivering cutting-edge solutions in the medical beauty sector.

In April 2025, CDP SWISS AG was acquired by Healthcare Holding Schweiz AG, a portfolio company of KKA Partners and Winterberg Group. This acquisition will enable Healthcare Holding Schweiz AG to further expand its medical technology portfolio across Switzerland's healthcare sectors. The company is expected to continue developing new products that will enhance its offerings in the medical aesthetic domain and may target new geographic markets for expansion, although specific regions and timelines have not been disclosed.